Home > Riviste > Minerva Obstetrics and Gynecology > Fascicoli precedenti > Minerva Ginecologica 2020 August;72(4) > Minerva Ginecologica 2020 August;72(4):219-28

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

ORIGINAL ARTICLE   Free accessfree

Minerva Ginecologica 2020 August;72(4):219-28

DOI: 10.23736/S0026-4784.20.04675-4

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

An innovative device in the management of female urodynamic stress incontinence: a perception survey

Marco SOLIGO 1 , Marco TORELLA 2, Matteo BALZARRO 3, Maria G. MATARAZZO 4, Andrea BRAGA 5, Maurizio SERATI 6 on behalf of the Italian Urodynamic Society (SIUD)

1 Unit of Urogynecology, Department of Woman, Mother, and Neonate, Buzzi Children’s Hospital, ASST Fatebenefratelli-Sacco, University of Milan, Milan, Italy; 2 Department of Gynecology, Obstetric and Reproductive Science, Second University of Naples, Naples, Italy; 3 Department of Urology, University Hospital of Verona, Verona, Italy; 4 Gynecological Clinic, University Polyclinic of Catania, Catania, Italy; 5 Department of Obstetrics and Gynecology, EOC-Beata Vergine Hospital, Mendrisio, Switzerland; 6 Department of Obstetrics and Gynecology, University of Insubria, Varese, Italy



BACKGROUND: Urinary incontinence significantly affects daily life of suffering women. Minimally invasive solutions to cope with urine leakage would be of great interest.
METHODS: A survey to investigate efficacy and compliance of an innovative intravaginal device (Diveen®) to reduce the risk of urine leakage was performed in 5 Urogynecological Centers across Italy. Women with urodynamic diagnosis of stress incontinence, included mixed conditions, underwent the survey.
RESULTS: The device was effective (60%) independently from severity of Incontinence or the presence of concomitant detrusor overactivity (mixed forms) with a positive impact on quality of life in more than half of the women. Also compliance with the device was satisfactory (up to 73%). Clinically symptomatic prolapse and age >65 years are the only limiting factors in terms of efficacy and compliance, while the menopausal status would not seem to affect these aspects.
CONCLUSIONS: Despite global satisfactory outcomes, 46% of the surveyed women declare their propensity to use the device. This data deserves further investigation.


KEY WORDS: Surveys and questionnaire; Urinary incontinence; Urodynamics; Quality of Life; Compliance

inizio pagina